BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22204167)

  • 1. Medicare Part D: challenges for dialysis patients. Part 1.
    Smith S; Witten B; Paykin C; Weiner S; Chianchiano D; St Peter WL
    Nephrol News Issues; 2011 Nov; 25(12):38-40, 42, 44-5. PubMed ID: 22204167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential impact of Medicare Part D in the end-stage renal disease population.
    St Peter WL
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):140-6. PubMed ID: 18334238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D.
    Frankenfield DL; Weinhandl ED; Powers CA; Howell BL; Herzog CA; St Peter WL
    Am J Kidney Dis; 2012 May; 59(5):670-81. PubMed ID: 22206743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orals in the bundle: a policy framework.
    Feldman RL; Desmarais MP; Muller JS
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):1043-7. PubMed ID: 23599409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growing cohort of seniors with HIV/AIDS: changing the scope of Medicare Part D.
    Flaer PJ; Benjamin PL; Malow RM; Morisky DE; Parkash J
    AIDS Care; 2010 Jul; 22(7):903-8. PubMed ID: 20635255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D.
    Yusuf AA; Howell BL; Powers CA; St Peter WL
    Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Medicare Part D doughnut hole: effect on pharmacy utilization.
    Sun SX; Lee KY
    Manag Care Interface; 2007 Sep; 20(9):51-5, 59. PubMed ID: 18161394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drugs in Medicare and the ESRD program.
    Powe NR
    Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Part D research highlights and policy updates, 2013: impact and insights.
    Stubbings J; Lau DT
    Clin Ther; 2013 Apr; 35(4):402-12. PubMed ID: 23541710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.
    Polinski JM; Mohr PE; Johnson L
    Arthritis Rheum; 2009 Jun; 61(6):745-54. PubMed ID: 19479704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How end-stage renal disease patients manage the Medicare Part D coverage gap.
    Kovacs PJ; Perkins N; Nuschke E; Carroll N
    Health Soc Work; 2012 Nov; 37(4):225-33. PubMed ID: 23301436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the impact of Part D on nursing home residents.
    Hudson N
    Find Brief; 2010 May; 13(4):1-3. PubMed ID: 21121179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.
    Kim MH; Lin J; Kreilick C
    Adv Ther; 2009 Aug; 26(8):784-94. PubMed ID: 19690820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.